医学
射血分数保留的心力衰竭
内科学
赛马鲁肽
心力衰竭
心脏病学
射血分数
体质指数
安慰剂
2型糖尿病
糖尿病
内分泌学
利拉鲁肽
病理
替代医学
作者
Mikhail Kosiborod,Steen Z. Abildstrøm,Barry A. Borlaug,Javed Butler,Louise Christensen,Melanie J. Davies,Kees Hovingh,Dalane W. Kitzman,Marie L.S. Lindegaard,Daniél Vega Møller,Sanjiv J. Shah,Marianne Bach Treppendahl,Subodh Verma,Mark C. Petrie
标识
DOI:10.1016/j.jchf.2023.05.010
摘要
In total, STEP-HFpEF program randomized 1,146 participants with the obesity phenotype of HFpEF and will determine whether semaglutide improves symptoms, physical limitations, and exercise function in addition to weight loss in this vulnerable group.
科研通智能强力驱动
Strongly Powered by AbleSci AI